Trial Profile
A phase 1/2a study of IGEM-F in ovarian cancer and other cancers
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 01 Dec 2022
Price :
$35
*
At a glance
- Drugs IGEM-F (Primary)
- Indications Cancer; Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Apr 2018 New trial record